A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors
Clinical trial NCT00742131 · COMPLETED
Trial details
- NCT number
- NCT00742131
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-17
- Primary completion
- 2008-05-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.